C2N Diagnostics
Fierce Medtech named C2N one of its Fierce 15 for 2020; "one of the most promising private companies in the industry.”
92 employees · est. 2007 · United States
Hemosure® is the older company (2007 vs 2003); C2N Diagnostics is the larger of the two.
Side-by-Side Comparison
| Metric | C2N Diagnostics | Hemosure® |
|---|---|---|
| Founded | ||
| Founded | 2007 | 2003 older |
| Headquarters | ||
| Headquarters | United States | Irwindale, United States |
| Employees | ||
| Employees | 92 larger | 25 |
| Industry | ||
| Industry | Biotechnology | Food and Beverage, Manufacturing |
| Funding Stage | ||
| Funding Stage | Corporate Round | Not tracked yet |
| Total Funding | ||
| Total Funding | $52.20M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 4 | Not tracked yet |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Medtech, Diagnostics, Therapeutic Discovery, Neurological Disorders, Blood Tests, Alzheimer’s Disease, Precision Medicine, Mass Spectrometry, Health Care, FDA Breakthrough Device, CE Mark, Protein Diagnostics, Neurodegeneration, Research And Development | Clinical Diagnostic Test Kits, FDA Cleared, Automated Immunochemical Fecal Occult Blood Diagnostic System, Healthcare Efficiency, Gastrointestinal Disorders, Rapid Diagnostics, Medical Diagnostics, Quality Of Life Improvement, Los Angeles Proximity, Medical Institutions Collaboration |
| Website | ||
| Website | c2ndiagnostics.com | hemosure.com |
About C2N Diagnostics
C2N Diagnostics, established in 2007 and headquartered in the United States, is a biotechnology startup making significant strides in the medical industry. The company's dedication to innovation and excellence has been acknowledged by Fierce Medtech, which named C2N one of its Fierce 15 for 2020, re...
About Hemosure®
Hemosure® Inc. has been leading the field of clinical diagnostic test kits and medical devices since 2003. The company prides itself on the enduring success of its Fecal Occult Blood test (iFOB), maintaining its position as the #1 test in the US for nearly a decade, showcasing its quality and effect...
We will tell you when either one moves
BounceWatch watches C2N Diagnostics and Hemosure® for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at C2N Diagnostics and Hemosure® — by email.
Frequently Asked Questions
Compare C2N Diagnostics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at C2N Diagnostics on 12 Sep 2024, and Hemosure® on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.